Liver mass pathophysiology: Difference between revisions
Line 17: | Line 17: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |[[Hepatocellular adenoma]] | ! align="center" style="background:#DCDCDC;" + |[[Hepatocellular adenoma]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Estrogens cause the transformation of hepatocytes via steroid receptors | * Estrogens cause the transformation of hepatocytes via steroid receptors | ||
* Results in generalized vascular ectasia | * Results in generalized vascular ectasia | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Transcription factor 1 gene (''TCF1'') | * Transcription factor 1 gene (''TCF1'') | ||
* Interleukin 6 signal transducer gene (''IL6ST'') | * Interleukin 6 signal transducer gene (''IL6ST'') | ||
* β catenin-1 gene (''CTNNB1'') | * β catenin-1 gene (''CTNNB1'') | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Glycogen storage disease types Ia and III | * Glycogen storage disease types Ia and III | ||
* Fanconi anemia | * Fanconi anemia | ||
Line 32: | Line 32: | ||
* Hurler disease | * Hurler disease | ||
* Galactosemia | * Galactosemia | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Well circumscribed | * Well circumscribed | ||
* Nonlobulated | * Nonlobulated | ||
* Smooth and soft | * Smooth and soft | ||
* White to yellow to brown lesions | * White to yellow to brown lesions | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Cords of hepatocytes that have a high glycogen and fat content | * Cords of hepatocytes that have a high glycogen and fat content | ||
* Lack of normal hepatic parenchymal architecture | * Lack of normal hepatic parenchymal architecture | ||
Line 43: | Line 43: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |[[Focal nodular hyperplasia]] | ! align="center" style="background:#DCDCDC;" + |[[Focal nodular hyperplasia]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Develop around a preexisting arterial malformation | * Develop around a preexisting arterial malformation | ||
* Production of growth factors promote growth of small arteries | * Production of growth factors promote growth of small arteries | ||
* Increased perfusion of the adjacent tissue results in peritumoral hyperplasia. | * Increased perfusion of the adjacent tissue results in peritumoral hyperplasia. | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* β-catenin gene (''CTNNB1'') | * β-catenin gene (''CTNNB1'') | ||
* ''TP53'' | * ''TP53'' | ||
* ''APC'' or HNF1α | * ''APC'' or HNF1α | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Klippel-Trénaunay-Weber syndrome | * Klippel-Trénaunay-Weber syndrome | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Well-circumscribed | * Well-circumscribed | ||
* Non-encapsulated | * Non-encapsulated | ||
* Central fibrous scar | * Central fibrous scar | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Hepatic parenchyma arranged in incomplete nodules | * Hepatic parenchyma arranged in incomplete nodules | ||
* Fibrous tissue with thick-walled vessels | * Fibrous tissue with thick-walled vessels | ||
Line 64: | Line 64: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |[[Hemangioma]] | ! align="center" style="background:#DCDCDC;" + |[[Hemangioma]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Congenital disorder | * Congenital disorder | ||
* Vascular malformations that enlarge by ectasia | * Vascular malformations that enlarge by ectasia | ||
* Estrogen and progesterone influence over tumor growth | * Estrogen and progesterone influence over tumor growth | ||
* More common in females | * More common in females | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Von Hippel Lindau disease | * Von Hippel Lindau disease | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Well-circumscribed | * Well-circumscribed | ||
* Appear red-brown | * Appear red-brown | ||
* Solitary nodules | * Solitary nodules | ||
* Less than 5cms | * Less than 5cms | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Large cystically dilated vessels | * Large cystically dilated vessels | ||
* Thin walls | * Thin walls | ||
Line 84: | Line 84: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" + |[[Hepatic cysts|Hepatic Cyst]] | ! align="center" style="background:#DCDCDC;" + |[[Hepatic cysts|Hepatic Cyst]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Von Meyenburg complexes separate from biliary tree and dilate to form cyst | * Von Meyenburg complexes separate from biliary tree and dilate to form cyst | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Single, unilocular cyst | * Single, unilocular cyst | ||
* Variable amounts of clear amber fluid (may contain blood, bile, mucus, pus) | * Variable amounts of clear amber fluid (may contain blood, bile, mucus, pus) | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Lined by flat / cuboidal epithelium | * Lined by flat / cuboidal epithelium | ||
* Epithelium rests on thin collagenous wall without spindle cell stroma | * Epithelium rests on thin collagenous wall without spindle cell stroma |
Revision as of 19:22, 27 November 2018
Liver Mass Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Liver mass pathophysiology On the Web |
American Roentgen Ray Society Images of Liver mass pathophysiology |
Risk calculators and risk factors for Liver mass pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
The exact pathogenesis of a liver mass depends upon the underlying disease. Increased estrogen in hepatic adenoma stimulates hepatocytes via steroid receptors and results vascular ectasia. While in FNH excessive release of growth factors promote growth of small arteries. Some conditions such as hemangioma, hepatic cysts are believed to be as result of genetic abnormality. Precancerous lesions are responsible for HCC, cholangiosarcoma. Hepatic abscess and echinoccosiosis are due to infectious agents.
Pathophysiology
The exact pathogenesis of a liver mass depends upon the underlying disease. The following table summarizes the various causes of liver masses:
Disease | Pathogenesis | Genetics | Associated Conditions | Gross Pathology | Microscopic Pathology |
---|---|---|---|---|---|
Hepatocellular adenoma |
|
|
|
|
|
Focal nodular hyperplasia |
|
|
|
|
|
Hemangioma |
|
|
|
| |
Hepatic Cyst |
|
|
| ||
Lymphangioma |
|
|
| ||
Angiomyolipoma |
|
|
| ||
Hepatocellular carcinoma |
|
|
|
| |
Cholangiocarcinoma |
|
|
|
| |
Hepatic abscess |
|
|
| ||
Parasitic cysts:[18][19][20](Echinococcous) |
|
|
|
References
- ↑ Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, Clément B, Balabaud C, Chevet E, Laurent A, Couchy G, Letouzé E, Calvo F, Zucman-Rossi J (2012). "Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma". Nat. Genet. 44 (6): 694–8. doi:10.1038/ng.2256. PMC 3819251. PMID 22561517.
- ↑ Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, Mandahl N, Meeker AK, Mertens F, Netto GJ, Rasheed BA, Riggins GJ, Rosenquist TA, Schiffman M, Shih I, Theodorescu D, Torbenson MS, Velculescu VE, Wang TL, Wentzensen N, Wood LD, Zhang M, McLendon RE, Bigner DD, Kinzler KW, Vogelstein B, Papadopoulos N, Yan H (2013). "TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal". Proc. Natl. Acad. Sci. U.S.A. 110 (15): 6021–6. doi:10.1073/pnas.1303607110. PMC 3625331. PMID 23530248. Vancouver style error: initials (help)
- ↑ Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J, Zucman Rossi J (2013). "High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions". Nat Commun. 4: 2218. doi:10.1038/ncomms3218. PMC 3731665. PMID 23887712.
- ↑ Chen YL, Jeng YM, Chang CN, Lee HJ, Hsu HC, Lai PL, Yuan RH (2014). "TERT promoter mutation in resectable hepatocellular carcinomas: a strong association with hepatitis C infection and absence of hepatitis B infection". Int J Surg. 12 (7): 659–65. doi:10.1016/j.ijsu.2014.05.066. PMID 24866078.
- ↑ Schulze K, Imbeaud S, Letouzé E, Alexandrov LB, Calderaro J, Rebouissou S, Couchy G, Meiller C, Shinde J, Soysouvanh F, Calatayud AL, Pinyol R, Pelletier L, Balabaud C, Laurent A, Blanc JF, Mazzaferro V, Calvo F, Villanueva A, Nault JC, Bioulac-Sage P, Stratton MR, Llovet JM, Zucman-Rossi J (2015). "Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets". Nat. Genet. 47 (5): 505–511. doi:10.1038/ng.3252. PMC 4587544. PMID 25822088.
- ↑ Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, Tsuji S, Donehower LA, Slagle BL, Nakamura H, Yamamoto S, Shinbrot E, Hama N, Lehmkuhl M, Hosoda F, Arai Y, Walker K, Dahdouli M, Gotoh K, Nagae G, Gingras MC, Muzny DM, Ojima H, Shimada K, Midorikawa Y, Goss JA, Cotton R, Hayashi A, Shibahara J, Ishikawa S, Guiteau J, Tanaka M, Urushidate T, Ohashi S, Okada N, Doddapaneni H, Wang M, Zhu Y, Dinh H, Okusaka T, Kokudo N, Kosuge T, Takayama T, Fukayama M, Gibbs RA, Wheeler DA, Aburatani H, Shibata T (2014). "Trans-ancestry mutational landscape of hepatocellular carcinoma genomes". Nat. Genet. 46 (12): 1267–73. doi:10.1038/ng.3126. PMID 25362482.
- ↑ Cleary SP, Jeck WR, Zhao X, Chen K, Selitsky SR, Savich GL, Tan TX, Wu MC, Getz G, Lawrence MS, Parker JS, Li J, Powers S, Kim H, Fischer S, Guindi M, Ghanekar A, Chiang DY (2013). "Identification of driver genes in hepatocellular carcinoma by exome sequencing". Hepatology. 58 (5): 1693–702. doi:10.1002/hep.26540. PMC 3830584. PMID 23728943.
- ↑ Fava, G.; Lorenzini, I. (2012). "Molecular Pathogenesis of Cholangiocarcinoma". International Journal of Hepatology. 2012: 1–7. doi:10.1155/2012/630543. ISSN 2090-3448.
- ↑ 9.0 9.1 Sirica A (2005). "Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy". Hepatology. 41 (1): 5–15. PMID 15690474.
- ↑ Holzinger F, Z'graggen K, Büchler M. "Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma". Ann Oncol. 10 Suppl 4: 122–6. PMID 10436802.
- ↑ Gores G (2003). "Cholangiocarcinoma: current concepts and insights". Hepatology. 37 (5): 961–9. PMID 12717374.
- ↑ Stain SC, Yellin AE, Donovan AJ, Brien HW (1991). "Pyogenic liver abscess. Modern treatment". Arch Surg. 126 (8): 991–6. PMID 1863218.
- ↑ Munro JC (1905). "VII. Lymphatic and Hepatic Infections Secondary to Appendicitis". Ann Surg. 42 (5): 692–734. PMC 1425980. PMID 17861705.
- ↑ Huang CJ, Pitt HA, Lipsett PA, Osterman FA, Lillemoe KD, Cameron JL; et al. (1996). "Pyogenic hepatic abscess. Changing trends over 42 years". Ann Surg. 223 (5): 600–7, discussion 607-9. PMC 1235191. PMID 8651751.
- ↑ Rahimian J, Wilson T, Oram V, Holzman RS (2004). "Pyogenic liver abscess: recent trends in etiology and mortality". Clin Infect Dis. 39 (11): 1654–9. doi:10.1086/425616. PMID 15578367.
- ↑ https://librepathology.org/wiki/Liver_pathology Accessed on February 22, 2017
- ↑ Lublin M, Bartlett DL, Danforth DN, Kauffman H, Gallin JI, Malech HL; et al. (2002). "Hepatic abscess in patients with chronic granulomatous disease". Ann Surg. 235 (3): 383–91. PMC 1422444. PMID 11882760.
- ↑ Tappe, Dennis, August Stich, and Matthias Frosch. "Emergence of Polycystic Neotropical Echinococcosis." Emerging Infectious Disease 14.2 (2008): 292-97. Web. 21 February 2010.
- ↑ Howorth, MB. "Echinococcosis Of Bone." Journal of Bone and Joint Surgery 27. (1945): 401-11. Web. 21 February 2010.
- ↑ Cox FE (2002). "History of human parasitology". Clin. Microbiol. Rev. 15 (4): 595–612. PMC 126866. PMID 12364371.